tldrdaily.news logo
Tag

Inhalers

All articles tagged with #inhalers

healthcare1 year ago

AstraZeneca Caps US Inhaler Costs at $35/month

AstraZeneca will limit out-of-pocket costs for inhalers and related medication to $35 per month starting June 1, aiming to assist uninsured patients with asthma or chronic obstructive pulmonary disease. This move follows pressure from lawmakers and a similar initiative by Boehringer Ingelheim, but GlaxoSmithKline and Teva have not committed to a price cap. The Asthma and Allergy Foundation of America supports efforts to make asthma drugs more affordable and urges all healthcare industry stakeholders to collaborate in reducing costs.

via The Washington Post|
#asthma#astrazeneca#healthcare
health1 year ago

"Challenges for Parents Seeking Generics for Kids with Asthma as Flovent Inhaler Goes Off Market"

After the discontinuation of Flovent inhaler, some parents are facing challenges in obtaining generic versions for their children with asthma. The transition from branded to authorized generics is expected to have minimal disruption for patients, but some insurance plans may cause delays if they don't cover the generic. The switch to generic versions may impact effectiveness on individual patients, as different types of inhalers require different usage techniques. GSK, the pharmaceutical company that made Flovent, has discontinued manufacturing the inhaler in the U.S. as of Jan. 1, 2024.

via Fox Business|
#asthma#flovent#generic-medication
business2 years ago

FTC Cracks Down on Illegal Patent Tactics by Drug Companies

The Federal Trade Commission (FTC) has issued a policy statement warning pharmaceutical companies about a patenting strategy that may be illegal and has contributed to high prices for inhalers. The strategy involves listing patents on inhalers in the federal registry known as the Orange Book, even if they are not directly related to the medication being delivered. This tactic deters generic competition and delays the availability of lower-priced alternatives. The FTC intends to scrutinize companies engaging in this practice, which could help accelerate the availability of affordable generic inhalers in the future.

via The New York Times|
#business#drug-companies#federal-trade-commission
health2 years ago

Expert tips to manage undiagnosed asthma and summer triggers.

On World Asthma Day, WHO experts offer 5 tips on how to manage asthma better. These include being aware of symptoms, identifying and avoiding triggers, knowing inhalers, using a spacer, and taking back control. Inhalers are considered essential medicines and should be available to all people living with asthma around the world. WHO is working to support countries to provide essential asthma interventions as part of universal health coverage, through technical tools and guidance.

via World Health Organization|
#asthma#health#inhalers